BR112012027970A2 - métodos, kits, combinação sequencial e uso de uma combinação - Google Patents

métodos, kits, combinação sequencial e uso de uma combinação

Info

Publication number
BR112012027970A2
BR112012027970A2 BR112012027970A BR112012027970A BR112012027970A2 BR 112012027970 A2 BR112012027970 A2 BR 112012027970A2 BR 112012027970 A BR112012027970 A BR 112012027970A BR 112012027970 A BR112012027970 A BR 112012027970A BR 112012027970 A2 BR112012027970 A2 BR 112012027970A2
Authority
BR
Brazil
Prior art keywords
combination
kits
methods
sequential
sequential combination
Prior art date
Application number
BR112012027970A
Other languages
English (en)
Inventor
Frederick Boylan John
He Wei
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of BR112012027970A2 publication Critical patent/BR112012027970A2/pt

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407Specifically defined cancers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52Assays involving cytokines
    • G01N2333/54Interleukins [IL]
    • G01N2333/5412IL-6
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/52Assays involving cytokines
    • G01N2333/54Interleukins [IL]
    • G01N2333/5421IL-8
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/52Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epidemiology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
BR112012027970A 2010-05-19 2011-05-17 métodos, kits, combinação sequencial e uso de uma combinação BR112012027970A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34624710P 2010-05-19 2010-05-19
PCT/EP2011/057909 WO2011144583A1 (en) 2010-05-19 2011-05-17 Combination therapy and method for assessing resistance to treatment

Publications (1)

Publication Number Publication Date
BR112012027970A2 true BR112012027970A2 (pt) 2019-09-24

Family

ID=44063206

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112012027970A BR112012027970A2 (pt) 2010-05-19 2011-05-17 métodos, kits, combinação sequencial e uso de uma combinação

Country Status (12)

Country Link
US (1) US8309299B2 (pt)
EP (1) EP2572198B1 (pt)
JP (1) JP5680744B2 (pt)
KR (2) KR101539138B1 (pt)
CN (1) CN102893155B (pt)
BR (1) BR112012027970A2 (pt)
CA (1) CA2798181A1 (pt)
ES (1) ES2488628T3 (pt)
HK (1) HK1176403A1 (pt)
MX (1) MX2012013305A (pt)
RU (1) RU2587053C2 (pt)
WO (1) WO2011144583A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102529007B1 (ko) * 2013-03-15 2023-05-03 나노바이오심 인크. 핵산들 및 단백질들의 모바일 디바이스 분석을 위한 시스템들 및 방법들
US10933417B2 (en) 2013-03-15 2021-03-02 Nanobiosym, Inc. Systems and methods for mobile device analysis of nucleic acids and proteins
JP6250351B2 (ja) * 2013-09-30 2017-12-20 シスメックス株式会社 好酸球性気道炎症に関する情報の取得方法およびそのような情報を取得するためのマーカー
CN106093217B (zh) * 2015-05-29 2019-02-22 中国人民解放军第三0二医院 一种评价中西药注射剂序贯联用间隔时间的方法
WO2020163222A1 (en) * 2019-02-04 2020-08-13 Promab Biotechnologies, Inc. Nucleic acid sequence encoding chimeric antigen receptor and a short hairpin rna sequence for il-6 or a checkpoint inhibitor
CN115698291A (zh) * 2020-05-28 2023-02-03 马萨诸塞大学 用于SARS-CoV-2调节的寡核苷酸

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH04325095A (ja) * 1991-04-26 1992-11-13 Tosoh Corp 抗ヒトil−6モノクロ−ナル抗体及び該抗体を使用するil−6の測定方法
JPH05215749A (ja) * 1992-02-07 1993-08-24 Toray Ind Inc ヒトインタ−ロイキン−8の免疫学的測定法
DK0968291T3 (da) * 1997-02-21 2004-06-07 Genentech Inc Antistoffragment-polymerkonjugater
CA2385614A1 (en) 1999-10-13 2001-04-19 Timothy Johann Multiplex cytokine analysis
US7349913B2 (en) 2003-08-21 2008-03-25 Microsoft Corporation Storage platform for organizing, searching, and sharing data
KR20070087233A (ko) 2003-09-09 2007-08-27 에프. 호프만-라 로슈 아게 감마-세크리테이즈의 활성을 차단하는 말론아미드 유도체
JP4880484B2 (ja) * 2004-02-20 2012-02-22 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア 唾液mRNAプロファイリング、バイオマーカーならびに関連した方法およびキット
JP4839674B2 (ja) * 2004-05-14 2011-12-21 東レ株式会社 標的物質を迅速簡便に検出する方法およびそのための酵素免疫学的キット
RU2440342C2 (ru) * 2006-03-27 2012-01-20 Ф.Хоффманн-Ля Рош Аг МАЛОНАМИДНЫЕ ПРОИЗВОДНЫЕ В КАЧЕСТВЕ ИНГИБИТОРОВ γ-СЕКРЕТАЗЫ
AU2007299129A1 (en) * 2006-09-20 2008-03-27 F. Hoffmann-La Roche Ag 4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]diazepine derivatives
AU2008209861B2 (en) * 2007-02-02 2012-08-09 F. Hoffmann-La Roche Ag 6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl derivatives
EP2147115A4 (en) * 2007-04-16 2010-05-05 CARDIOBIOINDEX / CARDIOBIOSCORE AND THE USE OF THE SPOKING PROTEOME IN CARDIOVASCULAR DIAGNOSTICS
EP2244713A1 (en) 2008-01-11 2010-11-03 F. Hoffmann-La Roche AG Use of a gamma-secretase inhibitor for treating cancer
CN101608222A (zh) * 2008-06-20 2009-12-23 上海主健生物工程有限公司 糖尿病遗传检测试剂盒

Also Published As

Publication number Publication date
KR20150065931A (ko) 2015-06-15
CA2798181A1 (en) 2011-11-24
EP2572198A1 (en) 2013-03-27
HK1176403A1 (zh) 2013-07-26
WO2011144583A1 (en) 2011-11-24
JP5680744B2 (ja) 2015-03-04
RU2012151434A (ru) 2014-06-27
KR20130009884A (ko) 2013-01-23
MX2012013305A (es) 2013-02-01
US8309299B2 (en) 2012-11-13
US20110287025A1 (en) 2011-11-24
CN102893155B (zh) 2016-01-20
ES2488628T3 (es) 2014-08-28
JP2013527454A (ja) 2013-06-27
EP2572198B1 (en) 2014-06-25
CN102893155A (zh) 2013-01-23
KR101539138B1 (ko) 2015-07-23
RU2587053C2 (ru) 2016-06-10
KR101718260B1 (ko) 2017-03-20

Similar Documents

Publication Publication Date Title
SMT201600226B (it) Alcune amminopirimidine, loro composizioni e metodi per il loro uso
BR112013025355A2 (pt) combinações de compostos de inibidor de akt e abiraterona e métodos de uso
BR112013007506A2 (pt) piridinonas/pirazinonas - métodos de criação e de uso
BR112013014119A2 (pt) novos moduladores e métodos de uso
BR112013006016A2 (pt) compostos de azabenzotiazol, composições e métodos de uso
BR112014014547A2 (pt) compostos antagonistas de e-selectina, composições e métodos de uso
BRPI1014316A2 (pt) composição, e, uso de uma composição
BR112012031232A2 (pt) método, dispositivo e uso
BR112015002364A2 (pt) composição de borracha. pneu e uso de uma composição de borracha
BRPI0908792A2 (pt) Composição, e, uso de uma combinação
BR112013010988A2 (pt) composição fluída e uso
BR112012031416A2 (pt) solução aceleradora e uso de uma solução aceleradora
BRPI1013421A2 (pt) composição parasticida tópica, e, uso de uma composição
BR112012017688A2 (pt) kits, conjuntos e métodos para instalação de sanitário sem uso de ferramentas
BR112014031412A2 (pt) método de preparação de uma composição, composição e seu uso, e kit.
BR112013013523A2 (pt) centralizador, método, e, uso de um centralizador
BR112013003536A2 (pt) composição, e utilização de uma composição.
BRPI0914793A2 (pt) Composição, e, uso de uma composição
CO6781486A2 (es) Compuestos y su uso
BRPI1012250A2 (pt) composição lubrificante, e, uso de uma composição lubrificante
BR112013012450A2 (pt) composições, métodos de detecção e kits
BR112013015891A2 (pt) uso de uma combinação, método de tratamento de um plasma e uso de uma combinação
BRPI1006996A2 (pt) composição, método e uso
BR112014010506A2 (pt) corda, e, uso de uma corda.
BRPI1011036A2 (pt) uso

Legal Events

Date Code Title Description
B08F Application fees: application dismissed [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2543 DE 01-10-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.